07-Oct-2026 18:04:54
NOVARTINDGeneral news
EVONILE PHARMA : CREDIT RATING ASSIGNED
• CARE Ratings Limited assigned CARE A; Stable to Long Term Bank Facilities and CARE A; Stable / CARE A2+ to Long Term / Short Term Bank Facilities. • The rating rationale is available on CARE Ratings Limited's website. • Information also available on the company's website: www.nilpharma.co.in. Impact: Credit rating outcome may influence future borrowing costs.
Novartis India Ltd
Open attachment